Advertisement

Amino Acids

, Volume 35, Issue 1, pp 29–36 | Cite as

Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases

  • M. A. Grillo
  • S. Colombatto
Review Article

Summary.

Advanced glycation end-products (AGEs) are formed from the so-called Amadori products by rearrangement followed by other reactions giving rise to compounds bound irreversibly. The structure of some of them is shown and the mechanism of formation is described. Several AGE binding molecules (Receptors for AGE, RAGE) are known and it is thought that many of the effects caused by AGEs are mediated by RAGE. Some of these were shown to be toxic, and called TAGE. The mechanism of detoxification of glyoxal and methylglyoxal by the glyoxalase system is described and also the possibility to eliminate glycated proteins by deglycation enzymes. Compounds able to inhibit AGEs formation are also taken into consideration.

Keywords: RAGE – TAGE – Detoxification – Amadorines 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahmed, N, Thornalley, PJ, Luthen, R, Haussinger, D, Sebekova, K, Schinzel, R, Voelker, W, Heidland, A 2004Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosisJ Hepatol41913919PubMedCrossRefGoogle Scholar
  2. Brown, TR, Su, B, Brown, KA, Scgwartz, MA, Tobia, AM, Kappler, F 2003Modulation of in vivo 3-deoxyglucosone levelsBiochem Soc Trans3114331437PubMedCrossRefGoogle Scholar
  3. Chen, F, Wollmer, MA, Hoerndli, F, Münch, G, Kuhla, B, Rogaev, ET, Tsolaki, M, Papassotiropoulos, A, Götz, J 2004Role for glyoxalase I in Alzheimer’s diseaseProc Natl Acad Sci USA10176877692PubMedCrossRefGoogle Scholar
  4. Choei, H, Sasaki, N, Takeuchi, M, Yoshida, T, Ukai, W, Yamagishi, S, Kikuchi, S, Saito, T 2004Glyceraldehyde-derived advanced glycation end products in Alzheimer’s diseaseActa Neuropathol108189193PubMedCrossRefGoogle Scholar
  5. Collard, F, Wiame, E, Bergans, N, Fortpied, J, Vertommen, D, Vanstapel, F, Delpierre, G, Van Schaftingen, E 2004Fructosamine 3-kinase-related protein and deglycation in human erythrocytesBiochem J382137143Google Scholar
  6. Creighton, DJ, Zheng, Z-B, Holewinski, R, Hamilton, DS, Eiseman, JL 2003Glyoxalase I inhibitors in cancer chemotherapyBiochem Soc Trans3113781382PubMedCrossRefGoogle Scholar
  7. Ding, Q, Keller, JN 2005Splice variants of the receptor for advanced glycosylation end products (RAGE) in human brainNeurosci Lett3736772PubMedCrossRefGoogle Scholar
  8. Dukic-Stefanovic, S, Schinzel, R, Riederer, P, Münch, G 2001AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?Biogerontology21934PubMedCrossRefGoogle Scholar
  9. Gugliucci, A, Menini, T 2003The polyamines spermine and spermidine protect proteins from structural and functional damage by AGE precursors: a new role for old moleculesLife Sci7226032616PubMedCrossRefGoogle Scholar
  10. Khalifah, RG, Baynes, JW, Hudson, BG 1999Amadorins: novel post-Amadori inhibitors of advanced glycation reactionsBiochem Biophys Res Commun257251258PubMedCrossRefGoogle Scholar
  11. Khula, B, Lüth, H-J, Haferburg, D, Boeck, K, Arendt, T, Münch, G 2005Methylglyoxal, glyoxal, and their detoxification in Alzheimer’s diseaseAnn NY Acad Sci1043211216CrossRefGoogle Scholar
  12. Ko, LW, Ko, EC, Nacharaju, P, Liu, WK, Chang, E, Kenessey, A, Yen, SH 1999An immunochemical study on tau glycation in paired helical filamentsBrain Res830301313PubMedCrossRefGoogle Scholar
  13. Kuhla, B, Boeck, K, Schmidt, A, Ogunlade, V, Arendt, T, Münch, G, Lüth, H-J 2007Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer’s disease brainsNeurobiol Aging282941PubMedCrossRefGoogle Scholar
  14. Lüth, H-J, Münch, G, Arendt, T 2002Aberrant expression of NOS isoforms in Alzheimer’s disease is structurally related to nitrotyrosine formationBrain Res953135143PubMedCrossRefGoogle Scholar
  15. Marasinghe, GPK, Sander, IM, Bennett, B, Periyannan, G, Yang, K-W, Makaroff, CA, Crowder, MW 2005Structural studies on a mitochondrial glyoxalase IIJ Biol Chem2804066840675PubMedCrossRefGoogle Scholar
  16. Méndez, JD, Leal, LI 2004Inhibition of in vitro pyrraline formation by L-arginine and polyaminesBiomed Pharmacother58598604PubMedCrossRefGoogle Scholar
  17. Picklo, MJ,Sr, Olson, SJ, Markesbery, WR, Montine, TJ 2001Expression and activities of aldo-keto oxidoreductases in Alzheimer diseaseJ Neuropathol Exp Neurol60686694PubMedGoogle Scholar
  18. Picklo, MJ,Sr, Montine, TY, Amarnath, V, Neely, MD 2002Carbonyl toxicology and Alzheimer’s diseaseToxicol Appl Pharmacol184187197PubMedCrossRefGoogle Scholar
  19. Richard, JP 1993Mechanism for the formation of methylglyoxal from triosephosphatesBiochem Soc Trans21549553PubMedGoogle Scholar
  20. Riederer, P, Hoyer, S 2006From benefit to damage. Glutamate and advanced glycation end products in Alzheimer brainJ Neural Transm11316711677PubMedCrossRefGoogle Scholar
  21. Sakamoto, H, Mashima, T, Sato, S, Hashimoto, Y, Yamori, T, Tsuruo, T 2001Selective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I – overexpressing human lung cancer cellsClin Cancer Res725132518PubMedGoogle Scholar
  22. Sasaki, N, Takeuchi, M, Chowei, H, Kikuchi, S, Hayashi, Y, Nakano, N, Ikeda, H, Yamagishi, S, Kitamoto, T, Saito, T, Makita, Z 2002Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jacob disease with prion plaquesNeurosci Lett326117120PubMedCrossRefGoogle Scholar
  23. Sasaki, N, Toki, S, Chowei, H, Saito, T, Nakano, N, Hayashi, Y, Takeuchi, M, Makita, Z 2001Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer’s diseaseBrain Res888256262PubMedCrossRefGoogle Scholar
  24. Sato, T, Iwaki, M, Shimogaito, N, Wu, X, Yamagishi, S, Takeuchi, M 2006TAGE (Toxic AGEs) theory in diabetic complicationsCurr Mol Med6351358PubMedCrossRefGoogle Scholar
  25. Sato, T, Shimogaito, N, Wu, X, Kikuchi, S, Yamagishi, S, Takeuchi, M 2006Toxic advanced glycation end products (TAGE) theory in Alzheimer’s diseaseAm J Alzheimers Dis Other Demen21197208PubMedCrossRefGoogle Scholar
  26. Schmidt, AM, Stern, DM 2000RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetesTrends Endocrinol Metab11368375PubMedCrossRefGoogle Scholar
  27. Schmidt, AM, Yan, SD, Yan, SF, Stern, DM 2001The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responsesJ Clin Invest108949955PubMedGoogle Scholar
  28. Szwergold, BS, Howell, S, Beisswengen, PJ 2001Human fructosamine-3-kinase: purification, sequencing, substrate specificity, and evidence of activity in vivoDiabetes5021392147PubMedCrossRefGoogle Scholar
  29. Takahashi, M, Pischetsrieder, M, Monnier, VM 1997Molecular cloning and expression of amadoriase isoenzyme (fructosyl amine:oxygen oxidoreductase, EC 1.5.3) from Aspergillus fumigatusJ Biol Chem2721250512507PubMedCrossRefGoogle Scholar
  30. Takeuchi, M, Kikuchi, S, Sasaki, N, Suzuki, T, Watai, T, Iwaki, M, Bucala, R, Yamagishi, S 2004Involvement of advanced glycation end-products (AGEs) in Alzheimer’s diseaseCurr Alzheimer Res13946CrossRefGoogle Scholar
  31. Tessier, F, Obrenovich, M, Monnier, VM 1999Structure and mechanism of formation of human lens fluorophore LM-1. Relationship to vesperlysine A and the advanced Maillard reaction in aging, diabetes, and cataractogenesisJ Biol Chem2742079620804PubMedCrossRefGoogle Scholar
  32. Thornalley, PJ 2003Glyoxalase I – structure, function and a critical role in the enzymatic defence against glycationBiochem Soc Trans3113431348PubMedGoogle Scholar
  33. Thornalley, P, Wolff, S, Crabbe, J, Stern, A 1984The autoxidation of glyceraldehyde and other simple monosaccharides under physiological conditions catalysed by buffer ionsBiochim Biophys Acta797276287PubMedGoogle Scholar
  34. Thornalley, PJ, Langborg, A, Minhas, HS 1999Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucoseBiochem J344109116PubMedCrossRefGoogle Scholar
  35. Usui, T, Shimohira, K, Watanabe, H, Hayase, F 2007Detection and determination of glyceraldehyde-derived pyridinium-type advanced glycation end product in streptozotocin-induced diabetic ratsBiosci Biotechnol Biochem71442448PubMedCrossRefGoogle Scholar
  36. Van Herreweghe, F, Mao, J, Chaplen, FW, Grooten, J, Gevaert, K, Vandekerckhove, J, Vancompermolle, K 2002Tumor necrosis factor-induced modulation of glyoxalase I activities through phosphorylation by PKA results in cell death and is accompanied by the formation of a specific methylglyoxal-derived AGEProc Natl Acad Sci USA99949954PubMedCrossRefGoogle Scholar
  37. Voziyan, PA, Hudson, B 2005Pyridoxamine. The many virtues of a Maillard reaction inhibitorAnn NY Acad Sci1043807816PubMedCrossRefGoogle Scholar
  38. Voziyan, PA, Khalifah, RG, Thibaudeau, C, Yildiz, A, Jacob, J, Serianni, AS, Hudson, B 2003Modification of proteins in vitro by physiological levels of glucose. Pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ionsJ Biol Chem2784661646624PubMedCrossRefGoogle Scholar
  39. Wiame, E, Delpierre, G, Collard, F, Van Schaftingen, E 2002Identification of a pathway for the utilization of the Amadori product fructoselysine in Escherichia coliJ Biol Chem2774252342529PubMedCrossRefGoogle Scholar
  40. Wong, A, Lüth, H-L, Deuther-Conrad, W, Dukic-Stefanovic, S, Gasic-Milenkovic, J, Arendt, T, Münch, G 2001Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer diseaseBrain Res9203240PubMedCrossRefGoogle Scholar
  41. Xu, Y, Chen, X 2006Glyoxalase II, a detoxifying enzyme of glycolysis byproduct methylglyoxal and a target of p63 and p73, is a pro-survival factor of the p53 familyJ Biol Chem2812671326702Google Scholar
  42. Yan, S-D, Chen, X, Schmidt, A-M, Brett, J, Godman, G, Zou, Y-S, Scott, CW, Caputo, C, Frappier, T, Smith, MA, Perry, G, Yen, S-H, Stern, D 1994Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stressProc Natl Acad Sci USA9177877791PubMedCrossRefGoogle Scholar
  43. Yang, BZ, Makita, Z, Horii, Y, Brunelle, S, Cerami, A, Sehajpal, P, Suthanthiran, M, Vlassara, H 1991Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relatioship to macrophage receptor for glucose-modified proteinsJ Exp Med174515524PubMedCrossRefGoogle Scholar
  44. Zyzak, DV, Richardson, JM, Thorpe, SR, Baynes, JW 1995Formation of reactive intermediates from Amadori compounds under physiological conditionsArch Biochem Biophys316547554PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • M. A. Grillo
    • 1
  • S. Colombatto
    • 1
  1. 1.Dipartimento di Medicina e Oncologia Sperimentale, Sezione di BiochimicaUniversità di TorinoTorinoItaly

Personalised recommendations